Inspire Medical Systems, Inc. (INSP) Shareholder Equity
- 2026-06-30: Preferred Stock, Value, IssuedUSD $0.00; Common Stock, Value, IssuedUSD $29.00K; Additional Paid in CapitalUSD $983.67M; Accumulated Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Net of TaxUSD (m).
- 2026-03-31: Preferred Stock, Value, IssuedUSD $0.00; Common Stock, Value, IssuedUSD $29.00K; Additional Paid in CapitalUSD $950.45M; Accumulated Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Net of TaxUSD (m).
- 2025-12-31: Preferred Stock, Value, IssuedUSD $0.00; Common Stock, Value, IssuedUSD $29.00K; Additional Paid in CapitalUSD $927.16M; Accumulated Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Net of TaxUSD $-100.00K.
- 2025-09-30: Preferred Stock, Value, IssuedUSD $0.00; Common Stock, Value, IssuedUSD $29.00K; Additional Paid in CapitalUSD $948.37M; Accumulated Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Net of TaxUSD $0.00.
Inspire Medical Systems, Inc. Shareholder Equity
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Preferred Stock, Value, Issued USD | Common Stock, Value, Issued USD | Additional Paid in Capital USD | Accumulated Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Net of Tax USD | Accumulated Other Comprehensive Income (Loss), Net of Tax USD | Retained Earnings (Accumulated Deficit) USD | Stockholders' Equity Attributable to Parent USD | APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition USD | Treasury Stock Acquired, Average Cost Per Share USD/shares | Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest USD |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $0.00 | $29.00K | $983.67M | (m) | $-645.00K | $-157.47M | $825.58M | 3 month · $31.23M | 3 month · 0.00 6 month · 0.00 | (m) |
| 2026-03-31 | $0.00 | $29.00K | $950.45M | (m) | $-352.00K | $-157.79M | $792.34M | 3 month · $30.69M | 3 month · 0.00 | (m) |
| 2025-12-31 | $0.00 | $29.00K | $927.16M | $-100.00K | $464.00K | $-146.49M | $781.16M | 12 month · $130.26M | (m) | (m) |
| 2025-09-30 | $0.00 | $29.00K | $948.37M | $0.00 | $639.00K | $-282.58M | $666.46M | 3 month · $29.47M | (m) | (m) |
| 2025-06-30 | $0.00 | $29.00K | $969.90M | $100.00K | $396.00K | $-292.51M | $677.81M | 3 month · $41.72M | 3 month · 0.00 6 month · 169.43 | (m) |
| 2025-03-31 | $0.00 | $29.00K | $924.41M | $-100.00K | $227.00K | $-288.92M | $635.74M | 3 month · $31.06M | 3 month · 169.43 | (m) |
| 2024-12-31 | $0.00 | $30.00K | $981.04M | $200.00K | $536.00K | $-291.91M | $689.70M | 12 month · $116.01M | (m) | (m) |
| 2024-09-30 | $0.00 | $30.00K | $1.02B | $300.00K | $1.70M | $-327.14M | $696.56M | 3 month · $28.22M | (m) | (m) |
| 2024-06-30 | $0.00 | $30.00K | $983.79M | $100.00K | $-115.00K | $-345.63M | $638.07M | 3 month · $32.32M | (m) | (m) |
| 2024-03-31 | $0.00 | $30.00K | $944.30M | $100.00K | $124.00K | $-355.43M | $589.02M | 3 month · $26.32M | (m) | $589.02M |
| 2023-12-31 | $0.00 | $30.00K | $917.11M | $200.00K | $800.00K | $-345.42M | $572.51M | 12 month · $82.47M | (m) | $572.51M |
| 2023-09-30 | $0.00 | $29.00K | $904.29M | $100.00K | $44.00K | $-360.19M | $544.18M | 3 month · $19.83M | (m) | $544.18M |
| 2023-06-30 | $0.00 | $29.00K | $880.87M | $100.00K | $103.00K | $-351.65M | $529.36M | 3 month · $21.57M | (m) | $529.36M |
| 2023-03-31 | $0.00 | $29.00K | $844.28M | $200.00K | $32.00K | $-339.69M | $504.65M | 3 month · $18.23M | (m) | $504.65M |
| 2022-12-31 | $0.00 | $29.00K | $820.34M | $-100.00K | $-86.00K | $-324.27M | $496.01M | 12 month · $51.97M | (m) | $496.01M |
| 2022-09-30 | $0.00 | $29.00K | $797.96M | $100.00K | $-363.00K | $-327.42M | $470.20M | 3 month · $14.59M | (m) | $470.20M |
| 2022-06-30 | $0.00 | $28.00K | $537.73M | (m) | $-201.00K | $-310.57M | $226.98M | 3 month · $12.66M | (m) | $226.98M |
| 2022-03-31 | $0.00 | $28.00K | $521.31M | (m) | $-198.00K | $-296.08M | $225.06M | 3 month · $9.72M | (m) | $225.06M |
| 2021-12-31 | $0.00 | $27.00K | $508.46M | $0.00 | $-55.00K | $-279.39M | $229.05M | 12 month · $26.18M | (m) | $229.05M |
| 2021-09-30 | $0.00 | $27.00K | $497.28M | (m) | $-9.00K | $-277.00M | $220.30M | 3 month · $6.81M | (m) | $220.30M |
| 2021-06-30 | $0.00 | $27.00K | $486.55M | (m) | $-12.00K | $-266.65M | $219.91M | 3 month · $6.34M | (m) | $219.91M |
| 2021-03-31 | $0.00 | $27.00K | $476.66M | (m) | $9.00K | $-253.56M | $223.13M | 3 month · $6.00M | (m) | $223.13M |
| 2020-12-31 | $0.00 | $27.00K | $467.04M | (m) | $29.00K | $-237.35M | $229.75M | 12 month · $12.82M | (m) | $229.75M |
| 2020-09-30 | $0.00 | $27.00K | $458.59M | (m) | $73.00K | $-229.86M | $228.82M | 3 month · $3.31M | (m) | $228.82M |
| 2020-06-30 | $0.00 | $27.00K | $452.89M | (m) | $154.00K | $-219.48M | $233.59M | 3 month · $2.90M | (m) | $233.59M |
| 2020-03-31 | $0.00 | $24.00K | $323.47M | (m) | $295.00K | $-196.39M | $127.40M | 3 month · $2.75M | (m) | $127.40M |
| 2019-12-31 | $0.00 | $24.00K | $319.87M | (m) | $102.00K | $-180.16M | $139.84M | 12 month · $6.20M | (m) | $139.84M |
| 2019-09-30 | (m) | $24.00K | $317.02M | (m) | $90.00K | $-171.08M | $146.05M | 3 month · $1.52M 9 month · $4.30M | (m) | $146.05M |
| 2019-06-30 | (m) | $24.00K | $315.24M | (m) | $51.00K | $-162.83M | $152.49M | 3 month · $1.39M 6 month · $2.78M | (m) | $152.49M |
| 2019-03-31 | (m) | $24.00K | $312.56M | (m) | $16.00K | $-155.18M | $157.42M | 3 month · $1.39M | (m) | $157.42M |
| 2018-12-31 | $0.00 | $23.00K | $310.94M | (m) | $-52.00K | $-146.91M | $164.00M | 12 month · $1.22M | (m) | $164.00M |
| 2018-09-30 | $0.00 | $21.00K | $240.45M | (m) | $-26.00K | $-142.13M | $98.31M | 3 month · $372.00K 9 month · $696.00K | (m) | $98.31M |
| 2018-06-30 | (m) | $21.00K | $240.00M | (m) | $0.00 | $-137.44M | $102.58M | 3 month · $269.00K 6 month · $324.00K | (m) | $102.58M |
| 2018-03-31 | $119.11M | $1.00K | $7.55M | (m) | (m) | $-131.59M | $-4.93M | 3 month · $55.00K | (m) | $-4.93M |
| 2017-12-31 | $119.11M | $1.00K | $7.30M | (m) | $0.00 | $-125.08M | $1.33M | 12 month · $243.00K | (m) | $1.33M |
| 2016-12-31 | (m) | (m) | (m) | (m) | (m) | (m) | $-6.61M | 12 month · $248.00K | (m) | (m) |
| 2015-12-31 | (m) | (m) | (m) | (m) | (m) | (m) | $-1.14M | (m) | (m) | (m) |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NovoCure Ltd (NVCR) | $1.886B | -11.87 | |
| LEMAITRE VASCULAR INC (LMAT) | United States | $1.848B | 33.37 |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |